FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

407124005: Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2150954019 Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2154160012 Levonorgestrel 0.015mg/day + oestradiol 0.045mg/day transdermal system en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2155183015 Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4741371000005114 levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system Is a levonorgestrel + estradiol, transdermalt system false Inferred relationship Some
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levonorgestrel false Inferred relationship Some
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Estradiol false Inferred relationship Some
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Progesterone false Inferred relationship Some
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system Has manufactured dose form kutan OG/ELLER transdermal doseringsform false Inferred relationship Some
    levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Climara pro levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system Is a False levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    US English

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start